2. Academic Validation
  3. Multitarget-directed drug design strategy: a novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects

Multitarget-directed drug design strategy: a novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects

  • J Med Chem. 2006 Nov 16;49(23):6642-5. doi: 10.1021/jm0608762.
Alessandra Antonello 1,  Andrea Tarozzi,  Fabiana Morroni,  Andrea Cavalli,  Michela Rosini,  Patrizia Hrelia,  Maria Laura Bolognesi,  Carlo Melchiorre
Affiliations

Affiliation

  • 1 Department of Pharmaceutical Sciences, Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.
PMID: 17154492 DOI: 10.1021/jm0608762
Abstract

The multifactorial mechanistic nature of Cancer calls for the development of multifunctional therapeutic tools, i.e., single compounds able to interact with multiple altered pathogenetic pathways. Following this rationale, we designed compounds able to irreversibly block epidermal growth factor receptor (EGFR), and to induce Apoptosis in tumor cell lines. The novel molecules were synthesized by combining the structural features of the EGFR inhibitor PD153035 (1) and lipoic acid, which among Other therapeutic effects triggers Apoptosis in human Cancer cells.

Figures